Your search for ‘Fulbright & Jaworski L.L.P.’ returned 53 results

Novartis Pharmaceuticals Canada Inc. ("Novartis") brought an application pursuant to s. 6 of the Patented Medicines (Notice of Compliance) Regulations for an order prohibiting the Minister of Health from issuing a notice of compliance to Teva Canada Limited ("Teva") in respect of Teva’s proposed zoledronate tablets until the expiry of Canadian Patent Nos. 1,338,895 (the "859 Patent") and 1,338,937 (the "937 Patent").

Apotex Inc. ("Apotex") brought an action for impeachment seeking a declaration that Lundbeck’s Canadian Patent No. 1,339,452 (the "’452 Patent") is invalid.

Teva Canada Limited ("Teva") and Apotex Inc. ("Apotex") wish to sell generic versions of GLEEVEC®.

The resolution of a lengthy challenge by a former University of Ottawa medical resident shows Canadian courts continue to uphold the freedom of universities to make their own academic decisions.

This month an eagerly anticipated hearing will be held before the Supreme Court of Canada in the high-profile Claude Robinson case.

Two long-awaited decisions from the Federal Court confirm that protection from discrimination on the ground of ‘‘family status’’ under the Canadian Human Rights Act includes childcare obligations.

We enclose an update of some recent noteworthy cases and developments concerning aboriginal law and the duty to consult.

Takings Whether Government May Deny Permits Based on Property Owner's Refusal to Pay for Unrelated Improvements.

On October 25, 2010, the Ontario "Not-for-Profit Corporations Act, 2010" (the Act) received royal assent.

Lanham Act disputes involve client assets that often are considered the most valuable assets of a business.